바이오제조 바이러스 검출 및 정량 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 제공 유형별, 기술별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Biomanufacturing Viral Detection and Quantifications Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering Type, By Technology, By Application, By End-User, By Region and Competition, 2020-2030F
상품코드:1770820
리서치사:TechSci Research
발행일:2025년 07월
페이지 정보:영문 198 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
바이오제조 바이러스 검출 및 정량 세계 시장은 2024년에 4억 9,346만 달러로 평가되었으며, 2030년에는 8억 3,586만 달러에 달하고, CAGR 9.14%로 성장할 것으로 예측됩니다.
이 시장은 임상, 환경 및 연구 샘플에서 바이러스 병원체를 검출하고 정량화하는 데 사용되는 시약, 기기 및 진단 시스템의 대규모 생산을 포괄합니다. 생명공학, 분자생물학, 공학의 원리를 통합한 바이오매뉴팩처링은 PCR, ELISA, 기타 분자진단과 같은 기술에 필수적인 도구의 일관되고 확장 가능한 개발을 가능하게 합니다. 이러한 기술은 진단 키트와 현장 진료 및 실험실에서 점점 더 많이 사용되고 있는 바이오센서 및 미세유체공학을 포함한 고처리량 플랫폼의 제작을 지원합니다. 이 분야는 바이러스의 신속한 탐지 및 측정을 가능하게 하고, 감시, 진단 및 대응 활동에서 전 세계 보건 시스템을 지원하는 데 중요한 역할을 하고 있습니다. 주요 분야로는 분자진단학, 면역진단학, 바이오센서 기술, 세포 기반 분석 등이 있으며, 이 모든 분야는 바이러스 위협을 적시에 식별하고 관리하는 데 기여하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
4억 9,346만 달러
시장 규모 : 2030년
8억 3,586만 달러
CAGR : 2025-2030년
9.14%
급성장 부문
ELISA
최대 시장
아시아태평양
시장 촉진요인
바이러스성 질환 증가
주요 시장 과제
빠르게 진화하는 바이러스
주요 시장 동향
신종 감염병 대비
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 바이오제조 바이러스 검출 및 정량 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제공 유형별(소모품, 기기, 서비스)
기술별(PCR, ELISA, 유세포 분석, 플라크 어세이, 기타)
용도별(혈액 및 혈액 제품 제조, 백신 및 치료제 제조, 세포 및 유전자 치료 제품 제조, 줄기세포 제품 제조, 조직 및 조직 제품 제조)
최종사용자별(생명과학 기업, 시험 기관, CRO, CDMO)
기업별(2024)
지역별
시장 맵
제6장 북미의 바이오제조 바이러스 검출 및 정량 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제7장 유럽의 바이오제조 바이러스 검출 및 정량 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 바이오제조 바이러스 검출 및 정량 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
한국
일본
호주
제9장 남미의 바이오제조 바이러스 검출 및 정량 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 바이오제조 바이러스 검출 및 정량 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
인수합병
제13장 PESTEL 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Danaher Corporation
Merck KGaA
New England Biolabs
TAKARA HOLDINGS INC.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Sartorius AG
Charles River Laboratories
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
The Global Biomanufacturing Viral Detection and Quantifications Market was valued at USD 493.46 million in 2024 and is projected to reach USD 835.86 million by 2030, growing at a CAGR of 9.14%. This market encompasses the large-scale production of reagents, instruments, and diagnostic systems used to detect and quantify viral agents in clinical, environmental, and research samples. Integrating biotechnological, molecular biology, and engineering principles, biomanufacturing enables the consistent and scalable development of tools essential for techniques like PCR, ELISA, and other molecular diagnostics. These technologies support the creation of diagnostic kits and high-throughput platforms, including biosensors and microfluidics, which are increasingly used in point-of-care and laboratory settings. The sector plays a critical role in enabling rapid virus detection and measurement, supporting global health systems in their surveillance, diagnosis, and response efforts. Key areas include molecular diagnostics, immunodiagnostics, biosensor technologies, and cell-based assays-all of which contribute to the timely identification and management of viral threats.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 493.46 Million
Market Size 2030
USD 835.86 Million
CAGR 2025-2030
9.14%
Fastest Growing Segment
ELISA
Largest Market
Asia Pacific
Key Market Drivers
Increasing Incidence of Viral Diseases
The growing prevalence of viral diseases is a primary driver accelerating the demand for advanced viral detection and quantification tools. As of 2024, the World Health Organization reported over 4.2 million dengue cases globally and more than 95,000 mpox (formerly monkeypox) cases since its outbreak in 2022. These figures reflect the increasing urgency for effective diagnostic tools to identify and contain viral infections early.
Biomanufactured products such as PCR kits, ELISA tests, and CRISPR-based diagnostics are vital for fast and accurate virus detection from clinical and environmental samples. These tools facilitate early diagnosis, rapid treatment initiation, and containment of infectious diseases. In settings where diseases like dengue are endemic, early quantification of viral load is essential to assess disease severity and determine appropriate clinical interventions. As new viral threats emerge, the need for deployable, high-performance diagnostic solutions continues to grow.
Key Market Challenges
Rapidly Evolving Viruses
One of the major challenges in the market is the ability of viruses to mutate rapidly, which can compromise the accuracy and reliability of diagnostic assays. Genetic mutations can affect the regions targeted by primers, probes, or antibodies, resulting in false negatives or decreased assay sensitivity.
To maintain diagnostic accuracy, biomanufacturers must continually update assay formulations to account for emerging variants. This requires ongoing investment in R&D and flexible production systems that can respond to evolving viral genomes. Ensuring optimal binding affinity and specificity under these conditions is complex and resource-intensive, posing a challenge to sustained product performance in the face of dynamic viral evolution.
Key Market Trends
Emerging Infectious Diseases Preparedness
Preparedness for emerging infectious diseases (EIDs) is shaping the future of the biomanufacturing viral detection and quantification market. This trend emphasizes the need for agile and responsive diagnostic capabilities that can be deployed during novel outbreaks.
Manufacturers are prioritizing the development of flexible diagnostic platforms that can quickly adapt to new pathogens. Scalable production and modular assay designs enable rapid shifts in manufacturing focus during global health emergencies. Fast-track regulatory approvals, collaborative efforts with public health agencies, and real-time surveillance capabilities are further reinforcing this trend.
Biomanufactured viral detection tools are not only crucial for diagnostics but also for tracking disease spread, evaluating vaccine effectiveness, and informing public health strategies during outbreaks. The growing emphasis on global health security is driving investment in platforms that support EID surveillance, detection, and response.
Key Market Players
Danaher Corporation
Merck KGaA
New England Biolabs
TAKARA HOLDINGS INC.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Sartorius AG
Charles River Laboratories
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc
Report Scope:
In this report, the Global Biomanufacturing Viral Detection and Quantifications Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Biomanufacturing Viral Detection and Quantifications Market, By Offering Type:
Consumables
Instruments
Services
Biomanufacturing Viral Detection and Quantifications Market, By Technology:
PCR
ELISA
Flow Cytometry
Plaque Assay
Others
Biomanufacturing Viral Detection and Quantifications Market, By Application:
Blood and Blood Products Manufacturing
Vaccines and Therapeutics Manufacturing
Cellular and Gene Therapy Products Manufacturing
Stem Cell Products Manufacturing
Tissue and Tissue Products Manufacturing
Biomanufacturing Viral Detection and Quantifications Market, By End User:
Life Science Companies
Testing Laboratories
CROs and CDMOs
Biomanufacturing Viral Detection and Quantifications Market, By Region:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Biomanufacturing Viral Detection and Quantifications Market.
Available Customizations:
Global Biomanufacturing Viral Detection and Quantifications Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Biomanufacturing Viral Detection and Quantifications Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Offering Type (Consumables, Instruments, Services)
5.2.2. By Technology (PCR, ELISA, FLOW Cytometry, Plaque Assay, Others)
5.2.3. By Application (Blood and Blood Products Manufacturing, Vaccine and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and tissue Products Manufacturing)
5.2.4. By End-User (Life Science Companies, testing Laboratories, CROs and CDMOs)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. North America Biomanufacturing Viral Detection and Quantifications Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Offering Type
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End-User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Biomanufacturing Viral Detection and Quantifications Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Offering Type
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End-User
6.3.2. Mexico Biomanufacturing Viral Detection and Quantifications Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Offering Type
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End-User
6.3.3. Canada Biomanufacturing Viral Detection and Quantifications Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Offering Type
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End-User
7. Europe Biomanufacturing Viral Detection and Quantifications Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Offering Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End-User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Offering Type
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End-User
7.3.2. Germany Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Offering Type
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End-User
7.3.3. United Kingdom Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Offering Type
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End-User
7.3.4. Italy Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Offering Type
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End-User
7.3.5. Spain Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Offering Type
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End-User
8. Asia-Pacific Biomanufacturing Viral Detection and Quantifications Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Offering Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End-User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Offering Type
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End-User
8.3.2. India Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Offering Type
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End-User
8.3.3. South Korea Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Offering Type
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End-User
8.3.4. Japan Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Offering Type
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End-User
8.3.5. Australia Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Offering Type
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End-User
9. South America Biomanufacturing Viral Detection and Quantifications Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Offering Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End-User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Biomanufacturing Viral Detection and Quantifications Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Offering Type
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End-User
9.3.2. Argentina Biomanufacturing Viral Detection and Quantifications Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Offering Type
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End-User
9.3.3. Colombia Biomanufacturing Viral Detection and Quantifications Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Offering Type
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End-User
10. Middle East and Africa Biomanufacturing Viral Detection and Quantifications Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Offering Type
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End-User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Biomanufacturing Viral Detection and Quantifications Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Offering Type
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End-User
10.3.2. Saudi Arabia Biomanufacturing Viral Detection and Quantifications Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Offering Type
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End-User
10.3.3. UAE Biomanufacturing Viral Detection and Quantifications Market Outlook
